Peer-reviewed veterinary case report
Best daily thiamazole dose to treat hyperthyroid cats
By Tang, Pak-Kan et al.·Published in Journal of veterinary internal medicine·2026·Department of Comparative Biomedical Sciences, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A predictive algorithm for the optimal daily dosage of thiamazole to control cats with hyperthyroidism.
- Species:
- cat
Plain-English summary
A group of cats with hyperthyroidism were treated with a medication called thiamazole to help manage their condition. Researchers developed a predictive tool to determine the best starting dose of thiamazole based on blood test results. They found that cats with higher levels of a hormone called TT4 and lower levels of creatinine were more likely to need a higher dose of thiamazole to control their hyperthyroidism effectively. The tool was very accurate, helping vets choose the right dosage for their feline patients.
People also search for: cat hyperthyroidism treatment · thiamazole dosage for cats · signs of hyperthyroidism in cats
Abstract
BACKGROUND: Hyperthyroidism is the most common endocrinopathy in cats and is frequently managed using anti-thyroid medication. HYPOTHESIS/OBJECTIVES: To develop and validate an algorithm to predict the optimal starting daily dose of thiamazole required to control hyperthyroidism in cats. ANIMALS: One hundred eighty-eight client-owned cats with hyperthyroidism for algorithm development (2011-2021) and 45 hyperthyroid cats to validate the algorithm (2022-2024). METHODS: Retrospective case-control study. Cats with hyperthyroidism controlled medically using thiamazole within a year since diagnosis were enrolled. Controlled dose of thiamazole was categorized into "≤5 mg" or ">5 mg." Binary logistic regression was performed to explore predictors associated with thiamazole dose. The performance of the final multivariable model in prediction was assessed by receiver operating characteristic (ROC) curve analysis. A cohort of cats subsequently diagnosed with hyperthyroidism and managed chronically with thiamazole were used to test algorithm performance. RESULTS: At hyperthyroidism diagnosis, baseline plasma total thyroxine (TT4); (odds ratio [OR] 1.29 [95% CI, 1.19-1.42] per 10 nmol/L; P < .001) and creatinine concentrations (OR 0.83 [95% CI, 0.7-0.96] per 0.1 mg/dL; P = .02) were independent predictors for higher thiamazole dose (>5 mg). The area under the ROC curve was 0.92 (95% CI, 0.88-0.96). In the test cohort, 26 cats controlled on ≤ 5 mg and 19 required >5 mg thiamazole. The predictive model had overall accuracy of 91.1%, sensitivity of 84.2%, and specificity of 96.2%. CONCLUSIONS AND CLINICAL IMPORTANCE: Hyperthyroid cats with higher plasma TT4 and lower creatinine concentrations at diagnosis are likely to require >5 mg total daily dose of thiamazole to achieve euthyroidism.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41742559/